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ABSTRACT
Trypanosoma cruzi, the aetiologic agent of Chagas disease, releases vesicles containing a wide
range of surface molecules known to affect the host immunological responses and the cellular
infectivity. Here, we compared the secretome of two distinct strains (Y and YuYu) of T. cruzi,
which were previously shown to differentially modulate host innate and acquired immune
responses. Tissue culture-derived trypomastigotes of both strains secreted extracellular vesicles
(EVs), as demonstrated by electron scanning microscopy. EVs were purified by exclusion chro-
matography or ultracentrifugation and quantitated using nanoparticle tracking analysis.
Trypomastigotes from YuYu strain released higher number of EVs than those from Y strain,
enriched with virulence factors trans-sialidase (TS) and cruzipain. Proteomic analysis confirmed
the increased abundance of proteins coded by the TS gene family, mucin-like glycoproteins, and
some typical exosomal proteins in the YuYu strain, which also showed considerable differences
between purified EVs and vesicle-free fraction as compared to the Y strain. To evaluate whether
such differences were related to parasite infectivity, J774 macrophages and LLC-MK2 kidney cells
were preincubated with purified EVs from both strains and then infected with Y strain trypomas-
tigotes. EVs released by YuYu strain caused a lower infection but higher intracellular proliferation
in J774 macrophages than EVs from Y strain. In contrast, YuYu strain-derived EVs caused higher
infection of LLC-MK2 cells than Y strain-derived EVs. In conclusion, quantitative and qualitative
differences in EVs and secreted proteins from different T. cruzi strains may correlate with
infectivity/virulence during the host–parasite interaction.
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Introduction
Trypanosoma cruzi cell surface is covered by a wide
range of molecules including members of trans-sialidase
(TS/gp85), mucin-like glycoproteins, mucin-associated
proteins (MASP) superfamilies, and proteases [1–3].
Those molecules are involved in attachment and inva-
sion to the host’s cell by infective forms of the parasite
[4–6]. Previous reports showed that some of those mole-
cules may act as proinflammatory agents during the
innate immune response [7] leading to the production
of nitric oxide (NO),IL-6, IL-12, and TNF-α via TLR2 by
macrophages [7,8]. Major parasite surface components,
such as TS/gp85 glycoproteins, mucins, and surface
proteases GP63, were found in extracellular vesicles
(EVs) shed by infective trypomastigote forms of the
parasite [9,10]. Trypanosoma cruzi EVs modulate infec-
tivity, since pre-treatment of BALB/c mice followed by
parasite challenge, exacerbated parasite load, heart
inflammation, and mortality [11]. Recently, protein
and α-galactosyl variations in EVs from different T.
cruzi strains (Y, Colombiana, CL-14, and YuYu) sug-
gested that intraspecies polymorphisms in those struc-
tures could correlate with their ability to induce
proinflammatory cytokines [12]. Several reports have
shown proteomic variations in different T. cruzi stages,
including cell derived trypomastigotes and epimasti-
gotes [12–16]. Recently, a proteomic analysis of secreted
material released by trypomastigotes obtained from
Vero cells infected with CL-Brener and VD strains
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identified several members of parasite surface molecules
[17]. However, a more detailed qualitative and quanti-
tative difference in EVs from T. cruzi strains is still
unknown.
Here, we performed a quantitative and qualitative
analysis of EVs and secreted vesicle-free (VF) fraction
of two T. cruzi strains (Y and YuYu) classified as TcI
and TcII [18], respectively. Those strains displayed
significant biological differences regarding infectivity
[19], drug resistance [11], and immunomodulation
[12]. Purified EVs and soluble fractions from Y and
YuYu strains were characterized by liquid chromato-
graphy-tandem mass spectrometry (LC-MS/MS)-based
proteomic analysis. Further, invasion was assessed after
preincubation of EVs in different cells (J774A.1 and
LLC-MK2) prior to trypomastigote exposure. Our find-
ings indicate that quantitative and qualitative differ-




The experimental procedures used in this work were
approved by the Ethics Committee on Animal Use
(CEUA) from the Federal University of São Paulo
(http://www.unifesp.br/reitoria/ceua/) protocol #382,321.
Cell lines and culture
Tissue culture-derived trypomastigotes (TCTs) from
YuYu and Y strains of T. cruzi were obtained from
the culture supernatants of green monkey (Rhesus)
kidney LLC-MK2 epithelial cells (ATCC® CCL-7™,
Manassas, VA). Cells were maintained in low glucose
Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% foetal bovine serum (FBS; Invitrogen,
Carlsbad, CA) at 37°C, 5% CO2. Parasites and mam-
malian cells were regularly tested for Mycoplasma [20].
Preparation of T. cruzi EVs and VF fractions
Culture supernatants containing TCTs were centrifuged at
1000 × g, 15 min, washed three times in phosphate-buf-
fered saline, pH 7.4 (PBS), and incubated for 2 h inDMEM
containing 2% glucose at 37°C, 5% CO2 for release of EVs.
The parasites (109 trypomastigotes per mL) were removed
by centrifugation (1000 × g, 10 min, room temperature),
and the supernatant (1 mL) was filtered, diluted 1:2 in
200 mM ammonium acetate, pH 6.5, and EVs purified
by size-exclusion chromatography (SEC) using a
Sepharose CL-4B column (1 × 40 cm, GE Healthcare,
Piscataway, NJ), pre-equilibrated with 100 mM ammo-
nium acetate, pH 6.5. After loading the filtered parasite
supernatant (1 mL), the column was eluted with the same
buffer at a flow rate of 0.2 mL/min. Fractions of 1 mL were
collected and then screened by nanoparticle tracking ana-
lysis (NTA) and enzyme-linked immunosorbent assay
(ELISA) to locate the fractions containing the EVs, as
previously described [21].
Soluble VF fraction was obtained by ultracentrifu-
gation for 16 h at 100,000 × g, 4°C, as described [13].
The ensuing supernatant contained soluble, secreted
proteins released by the parasite, and the pellet total
EVs. For proteomic analysis, pooled preparations of
purified total EVs or VF fractions were subjected to
(LC-MS/MS), as previously described [10,13], with
some modifications (see below). The experimental
workflow including the purification and characteriza-
tion of EVs and VF fraction is depicted in Figure 1.
Scanning electron microscopy (SEM)
TCT forms from both strains were fixed in a 2.5%
glutaraldehyde solution according to established pre-
paration protocols. Briefly, samples were washed in
0.1 M cacodylate solution, fixed with osmium tetrox-
ide, treated with tannic acid, dehydrated with ethanol,
and dried in a CPD 030 critical point dryer. The
samples were coated with a gold layer using a sputter-
ing method (‘sputtering’, © Leica EM 500 SCD,
Germany). Then, samples were observed in a Field
Emission FEI Quanta 250 FEG scanning electron
microscope [10,21].
Nanoparticle tracking analysis
EVs from both strains were diluted 100 × in PBS and
analysed by using by NTA using a LM10 equipment
(Malvern, UK) coupled to a CCD camera and a laser
emitting a 60-mW beam at 405-nm wavelength. Data
were analysed using Nanoparticle Tracking Analysis
(NTA) software (version 2.3 build 0017). The detection
threshold was set to 10. ‘Blur’, ‘Min track Length’, and
‘Min Expected Particle Size’ were set to auto. Readings
were taken in triplicates during 30 s at 25 frames per
second, camera level set to 9, and manual monitoring
of temperature (20°C). Differences in concentration
and modal size of the EVs were analysed by multiple
comparisons and corrected for multiple testing (one-
way ANOVA with post hoc Tukey’s test), assuming
values of p < 0.05 to be significant as described ear-
lier [10].
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Western blotting
Samples containing 30 μg of protein, quantified by BCA
technique (Thermo Fisher Scientific), were applied in
each lane, resolved in a 12% SDS-PAGE, and transferred
to nitrocellulose membranes using standard procedures.
Membranes were incubated with anti-T. cruzi trypo-
mastigote antibodies [22], monoclonal antibody (mAb)
anti-cruzipain (provided by Dr. Ana Paula Lima, Univ.
Fed. Rio de Janeiro, Brazil) or mAb 39 anti-TS [23].
Binding was detected after incubation for 1 h at room
temperature with the respective peroxidase-conjugated
secondary antibody (goat anti-mouse or rabbit IgG) by
ECL (Pierce) using an image apparatus.
Sample preparation for LC-MS/MS analysis
EVs (500 µg of protein) were concentrated in Speedvac
for 1–2 h and resuspended in 100 µL of 8 M urea
solution containing 100 mM Tris-HCl pH 8 (Kinder
and Sherman 2000). The samples were reduced by
adding 5 µL of dithiothreitol 1 M to a final concentra-
tion of 10 mM followed by 1 h incubation at 56°C.
Samples were then alkylated by adding 20 µL iodoace-
tamide 1 M to a final concentration of 50 mM followed
by 1 h incubation at room temperature in the dark.
SEC-purified EVs were diluted to 3 volumes by adding
100 mM ammonium acetate and digested with proteo-
mics-grade trypsin (Sigma-Aldrich) at 1:50 ratio of
enzyme:sample for 16 h at 37°C. To stop the reaction,
2 µL of glacial acetic acid was added. Digested samples
were concentrated in Speedvac (1–2 h), resuspended in
400 µL 0.1% trifluoroacetic acid (TFA), and desalted
using Sep-Pak TC18 Light silica-based bonded phase
columns (Millipore). The columns were pre-condi-
tioned with 2 mL methanol, 2 mL of 0.1% TFA in
50% acetonitrile (ACN), then 2 mL 0.1% TFA before
loading the samples. Then, the columns were washed
with 4 mL 0.1% TFA and eluted with 2 mL of 0.1%
TFA in 50% ACN.
Figure 1. Workflow employed for the production, fractionation, and characterization of Trypanosoma cruzi EVs and vesicle-free
fraction from Y and YuYu strains. The details of each step are explained in the Materials and Methods section. DMEM, Dulbecco’s
Modified Eagle’s Medium; NTA, nanoparticle tracking analysis; SEM, scanning electron microscopy; SEC, size-exclusion
chromatography.
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VF fractions (~10 μg protein) of YuYu and Y
strains, obtained as described above, were analysed by
high-resolution MS/MS, following digestion of proteins
using the filter-aided sample preparation (FASP)
method [24], according to the manufacturer’s protocol
(Expedeon, San Diego, CA). First, reduction in disul-
phide bonds of proteins was achieved by treatment
with 10 mM dithiothreitol (DTT) for 30 min at room
temperature (rt), under constant agitation. Samples
were placed on the FASP 30 kDa-cut-off spin filter
and centrifuged at 14,000xg for 15 min, at rt.
Although the filter cut-off was 30 kDa, we did not
observe significant loss of proteins of lower molecular
masses (10–30 kDa), using a HeLa whole cell lysate
(catalogue # 88,328, Pierce, Thermo Fisher Scientific)
and T. cruzi trypomastigote lysate as controls (data not
shown). Samples were then washed on filter twice with
8 M urea in 50 mM Tris-HCl Buffer (pH 8.0; urea/Tris-
HCl buffer, no DTT present), alkylated in the dark for
30 min at rt. Samples were washed again 2 × with the
urea/Tris-HCl buffer and 2 × with 50 mM ammonium
bicarbonate. A final wash step with 50 mM ammonium
bicarbonate was performed prior to transferring the
filter to a new tube and incubating with 4 µg proteo-
mics-grade trypsin (Sigma-Aldrich, St. Louis, MO),
dissolved in 100 µL 50 mM ammonium bicarbonate,
overnight at 37°C, for in-solution digestion, since the
proteins were retained but not absorbed to the 30-kDa
filter insert. Peptides were eluted from the filter using
200 µL 0.1% formic acid. Samples were dried to ~50-µL
volume and subjected to high-resolution LC-MS/MS
analysis in a QE Orbitrap (Thermo Fisher Scientific),
as described below.
LC-MS/MS and bioinformatics analysis
Tryptic peptides from EV fractions obtained by SEC
were resuspended in 0.1% formic acid and injected into
an EASY-nLC II nanoflow liquid chromatography sys-
tem (Thermo Fisher Scientific) in tandem with an
LTQ-Orbitrap Velos mass spectrometer (Thermo
Fisher Scientific), at a flow rate of 200 nL/min, in a
linear gradient from 5% to 40% mobile phase B (0.1%
formic acid in 100% acetonitrile) for 90 min. Samples
were separated by capillary reversed-phase C18 fritted-
tip analytical column (ID 75 μm × OD 360 μm, 10 cm
length), in-house packed with 5-μm Aqua C18 (125Å,
Phenomenex, Torrance, CA). Full scans (MS1) were
acquired in the Orbitrap analyzer with a resolution of
60,000, at the 300–1800 m/z range. The 20 most intense
ions were selected for MS/MS (minimum signal 5000)
and fragmented by CID (35% power, activation Q
0.250 s, and 10 ms activation time) and detected in
the ion trap. For all cluster events, 70 s dynamic exclu-
sion of ions was enabled to minimize repeated frag-
mentation. Ions clustering for more than once within
25 s were excluded from the selection. Mass spectrum
raw files were converted to a peak list format (mgf) by
MS Convert software (ProteoWizard), and data proces-
sing was performed using Mascot version 2.2 (Matrix
Science) against the T. cruzi database downloaded from
UniProt, with the following parameters: MS1 mass
tolerance of 10 ppm, MS2 mass tolerance of 0.5 Da;
trypsin as enzyme; carbamidomethylation of cysteine
as fixed modification, oxidation of methionine as vari-
able modification. Maximum false peptide and protein
discovery rate (FDR) was 1%. Label-free quantitative
analysis of Mascot proteomic data was achieved by
spectral counting after calculating the exponentially
modified protein abundance index (emPAI) for each
identified protein [25] (http://www.matrixscience.com/
help/quant_empai_help.html). Statistical analysis of the
label-free, spectral counting quantitative data was per-
formed by a two-sided Student’s t test, with p < 0.05
(http://www.matrixscience.com/help/quant_statistics_
help.html).
High-resolution MS/MS (HR-MS/MS) analysis of VF
fractions of YuYu and Y strains was performed on a Q
Exactive Plus Hybrid Quadrupole-Orbitrap MS
(Thermo Fisher Scientific), equipped with a Nanospray
Flex Ion Source (Thermo Fisher Scientific). Peptides
were separated using a Dionex UltiMate 3000
RSLCnano UHPLC system (Thermo Fisher Scientific),
with a PicoFrit column (75-μm ID × OD 360 μm, 25-cm
length, New Objective, Woburn, MA), in-house packed
with a reversed phase Aqua C18 porous silica (5 μm,
125Å, Phenomenex). Before sample injection, the col-
umn was equilibrated at a flow rate of 0.5 μL/min with
95% Solvent A (100% H2O, 0.1% formic acid) and 5%
Solvent B (90% acetonitrile, 0.1% formic acid). Five
microlitres of each sample (equivalent to 1 µg protein)
was then injected onto the C18 column, and the same
equilibration phase was run for 10 min. Elution of the
peptides was achieved with a gradient of Solvent B up to
35%, for 85 min, followed by a 5-min increase to 95%,
where the plateau was maintained for 9 min. The col-
umn was then re-equilibrated to 5% Solvent B for
10 min before injection of the next sample. An auto-
mated 2-h run was programmed into Xcalibur software
(Thermo Fisher Scientific), and each sample was ana-
lysed in technical duplicates with three biological repli-
cates. Between samples, two blank runs with 60-min
double seesaw washes using 5–80% ACN gradient to
optimally clean the resolving column and limit peptide
carryover. During each analysis and all sample runs, the
Q Exactive Plus was operated in top-10 data-dependent
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mode, which comprises 10 data-dependent MS/MS
scans for each preceding full scan. The Q Exactive Plus
settings were as follows: the normalized collision energy
for HCD was 28 eV; a full scan resolution of 70,000, at
400–1600 m/z range; a HCD-MS/MS resolution of
17,500 with an isolation width of 3 m/z; and dynamic
exclusion set at 15 s. Peptides were not excluded based
on charge state and 1 microscan for both full and MS/
MS scans were acquired. All MS and MS/MS data were
acquired in profile mode.
Resulting MS/MS spectra from HR-MS/MS analysis of
VF fractions of YuYu and Y strains were searched with
Proteome Discoverer (PD) 2.1.1.21 (Thermo Fisher
Scientific) and filtered via Percolator with an estimated
false-discovery rate (FDR) of 1%. The PD settings were
as follows: HCD-MS/MS; cysteine carboxyamidomethyla-
tion as fixed modification; methionine oxidation and acet-
ylation on any amino acid as variable modifications; fully
tryptic peptides only; up to 2 missed cleavages; parent ion
mass tolerance of 10 ppm (monoisotopic); and fragment
mass tolerance of 0.6 Da (in Sequest) and 0.02 Da (in PD
2.1.1.21; monoisotopic). Proteins were identified with a
minimum of two high-confidence peptides. Tandem MS/
MS spectra were searched against a combined protein
database of T. cruzi (downloaded in FASTA format on
20 January 2017, from UniProtKB; http://www.uniprot.
org/; 44,111 entries) and common contaminant sequences
(trypsin, human keratins, and protein lab standards, down-
loaded from http://compbio.ornl.gov/shewanella_chro
mium_stress/databases/) were included in this combined
database. The resulting PD dataset was further processed
through Scaffold Q + 4.8.2 (Proteome Software, Portland,
OR) to obtain the protein quantification. Files were
exported from Scaffold 4.8.2 for further analysis in
Scaffold perSPECtives (Proteome Software), where the
quantitative analysis (by normalized, weighted spectral
counting) and statistical analysis (two-tailed ANOVA,
control FDR with standard Benjamin-Hochberg proce-
dure, FDR level q = 0.05) were performed. A protein
threshold of 99%, peptide threshold of 95%, and a mini-
mum number of 2 peptides were used for identification of
proteins. Quantification was performed with normalized
weight spectral counts. Statistical analysis was carried out
using ANOVA with Benjamin-Hochberg multiple test
correction, and significance level of p < 0.05. Gene ontol-
ogy (GO) annotation was carried out using NCBI database
(downloaded on 14 February 2017, and 3 October 2017).
Infection of murine macrophages and epithelial
cells
Immortalized murine J774A.1 macrophages (phagocy-
tic) and LLC-MK2 epithelial cells (non-phagocytic)
were grown in 24-well dishes on 13 mm circular glass
coverslips (Glasscyto) in RPMI and DMEM, respec-
tively. Cells were washed twice with their respective
media and were incubated with EVs from Y and
YuYu strains (1 and 10 μg protein/well) for 1 h, at
37°C, in RPMI and/or DMEM containing 10% FBS.
Cells were infected with TCTs of the Y strain (MOI
1:50), for 2 h at 37°C, and then washed twice with
RPMI and/or DMEM without FBS. Non-adherent
parasites were removed by two washes with PBS. The
cells were then incubated with RPMI and/or DMEM
containing 10% FBS for 18 h, at 37°C, or immediately
fixed with methanol and stained with 4ʹ,6-diamidino-2-
phenylindole, dihydrochloride (DAPI, Molecular
Probes, Invitrogen Co., Carlsbad, CA). All experiments
were performed in triplicate, and 24 images of each
replicate were obtained using a digital video-imaging
fluorescent inverted microscope (Nikon), enabling
counting of infected and noninfected cells and intra-
cellular amastigotes [26].
Results
Fractionation and characterization of T. cruzi
vesicles
Confirming previous results under the same conditions
[10], TCTs from each strain were also able to release
EVs (Figure 2(a–c)). YuYu TCTs released larger
amounts of EVs (Figure 2(d–f)) and putative EVs
aggregates (Figure 2(g–i)).
After fractionation in Sepharose CL-4B column, EV-
containing eluted fractions were probed using total
anti-T. cruzi antibodies and characterized by NTA.
Typical elution patterns of several experiments are
represented (Figure 3). EVs from both strains exhibited
different size populations in their respective fractions
(10–40 mL). Nevertheless, the mean size of the EVs
was around 150 nm for both strains (Figure 3, inset,
left panel). The mean concentration of particles in the
YuYu strain (1.0 × 107–9.7 × 109 particles/mL) was
higher than in Y strain (2.7 × 106–8.9 × 108 particles/
mL; Figure 3, inset, right panel). Those data confirmed
previous SEM results (Figure 2). As expected, no par-
ticles were found in the medium alone (negative con-
trol; data not shown).
EVs from Y strain were highly reactive with anti-α-
Gal antibodies from patients with chronic Chagas
disease that recognize α-Gal epitopes when compared
to those from YuYu strain [10]. Hence, all fractions
from each strain were pooled and subjected to immu-
noblotting to preliminarily assess their composition.
EVs isolated from Y strain showed a different
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labelling with antibody that reacts with total mem-
branes of T. cruzi with a predominant reactivity to an
85 kDa band when loading the same amount of pro-
tein in the gel (Figure 4(a)). In contrast, YuYu strain
showed a higher reactivity for TS (Figure 4(b)) and
cruzipain (Figure 4(c)).
Proteomic analysis
Next, by proteomic analysis, we investigated the compo-
sitional differences between YuYu and Y strain EVs,
purified by gel-exclusion chromatography on a
Sepharose CL-4B column (Figure 1). We also identified
the proteins present in the VF fractions obtained by
ultracentrifugation at 100,000 × g, for 16 h, of conditioned
medium from trypomastigotes of Y and YuYu strains,
which also might contain proteins weakly associated with
EVs (Figure 1). In Supplementary Table 1A, we listed the
main proteins identified in the EVs from 5 and 8 biolo-
gical replicates (biosamples) from EVs of Y and YuYu
strains, respectively, obtained by gel-exclusion chromato-
graphy, and from 2 and 3 biological replicates (each with
two technical replicates) of VF fractions obtained by
ultracentrifugation of total secretome of Y and YuYu
strains, respectively. The majority of identified proteins
corresponded to members of the TS superfamily followed
by mucins, MASPs, and surface proteases GP63, which
were mainly in the both EV fractions. Proteins from
cytoskeletal proteins, such as tubulin, heat shock proteins,
and other soluble proteins, were detected in the VF and
total EV fractions of both strains and could correspond to
vesicle-entrapped and later released proteins, or contami-
nants of the preparation. At least four major groups (I, II,
V, and VIII) [26] of TS proteins were observed, being
group V the most abundant in EVs of Y and YuYu
strains, in terms of total and average spectral counts
(Supplementary Table 1B, underlined numbers).
Venn diagrams in Figure 5(a) show the comparison of
similar peptides detected in both the VF fractions and EVs
of the two strains. Most of the peptides identified were
found in the soluble fraction and were predominant for Y
strain. Consequently, a similar number of peptides were
detected in the EV fraction of both strains: 933 and 504 in
Y and YuYu, respectively. However, only 61 peptides were
common between them, suggesting a different composi-
tion. When considering the individual proteins identified,
the YuYu strain presented at least twice the number of
proteins exclusively found in the membrane bound frac-
tion of EVs, when compared to Y strain (Figure 5(b)).
Those data confirmed that EVs from YuYu strain are
enriched with proteins associated with the membrane.
Furthermore, clustering analysis illustrated the differential
Figure 2. SEM of T. cruzi trypomastigotes from Y and YuYu strains showing shedding of EVs. Each panel shows trypomastigotes pre-
incubated in DMEM with 2% glucose and attached to glass coverslips containing poly-lysine obtained from the Y (a) and YuYu
strains (b), fixed and processed for SEM. The bar sizes are indicated in each image.
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composition of EVs in both strains and in the supernatant
fraction of Y strain. As shown in the summary of the
Supplementary Table 1A, more proteins of the TS super-
family and the dispersed gene family 1 (DGF-1) hits were
found in the YuYu than in the Y strain. Mucins, mucin-
associated proteins, and cysteine peptidases were more
detected in the EVs of YuYu and in the VF of Y strain,
while the opposite situation was found for the GP63. YuYu
also contain more cytosolic and mitochondrial proteins in
the EV fraction, suggesting that their vesicles were more
stable and do not release their contents during shedding
and/or purification processes.
The distribution of the proteins based on GO analysis
showed larger number of hits in the EVs of YuYu strain
for cellular and metabolic processes compared to Y strain
(Figure 6). Similar enrichment was observed for proteins
located in the cytosol and intracellular organelles, sup-
porting the notion that EVs of YuYu strain encloses more
molecules than EVs of the Y strain.
EVs from different strains cause different infection
profiles
Since main differences in EVs derived from YuYu and Y
strains were in proteins known to act during the pro-
cesses of cell adhesion and infection [5,22,27,28], their
role during invasion was evaluated in phagocytic J774A.1
macrophages and non-phagocytic LLC-MK2 cells. Cells
were pre-incubated for 1 h with EVs from both strains
Figure 3. Sepharose 4B elution profile of EVs released by T. cruzi trypomastigotes. Total shed vesicles obtained from trypomastigotes (Y,
broken lines and YuYu, full line) and control (DMEM and 2% glucose, dotted line) were submitted to gel filtration chromatography using
Sepharose CL-4B column and 1 mL fractions were collected. (a) Reactivity of each fraction to antibody 460 was determined by ELISA, and
the results are expressed by absorbance at 450 nm. (b) Size (nm) and (c) concentration (particles/mL) of EVs from each fraction as
determined by NTA analysis. This figure represents a typical analysis of at least three independent experiments.
Figure 4. The protein expression profile in EVs is different in Y
and YuYu strains of the parasite. Immunoblot of the pooled
fractions of EVs released by the Y and YuYu strains probed with
antibody 460 (a), ant-TS (b), and anti-cruzipain (c). In the right
are indicated the position of mass standards in kDaltons.
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and then exposed to TCT of the Y strain for 2 h. EVs
from Y strain increased the number of J774A.1 macro-
phages infected with T. cruzi (Figure 7(a)). In general,
this affect was not dependent on protein concentration
(Figure 7(a–e); Figure 8(a–d)). Interestingly, pre-treated
cells with YuYu EVs showed larger numbers of intracel-
lular parasites (Figure 7(d-e)). Different from macro-
phages, in non-phagocytic cells, an increased
internalization of trypomastigotes in the presence of
EVs from YuYu strain was detected (Figure 8(a)).
However, intracellular proliferation of amastigotes was
lower than that of phagocytic cells (Figure 8(b–d)).
Discussion
EVs from T. cruzi strains (Y and YuYu), previously
known to have different biological and immunomodula-
tion properties [10,29], were evaluated. Also, their soluble
proteins (VF) were assessed. Similar to whole parasite,
YuYu EVs were enriched with TS family of glycoproteins,
mucins, and mucin-associated proteins when compared
to those from Y strain. Those molecules are well-estab-
lished T. cruzi virulence factors [1,5,7,8,30–34]. Both
strains were able to release EVs suggesting that similar
mechanisms of their biogenesis may occur among differ-
ent T. cruzi groups [18,35]. An interesting feature
observed for YuYu strain is its ability to release a higher
amount of EVs than Y strain as confirmed by SEM and
NTA. This feature may be also strain specific since YuYu
and Y strains belong to TcI and TcII groups, respectively
[18]. Although both EVs showed similar sizes, they exhib-
ited intraspecies polymorphisms in their contents con-
firming preliminary qualitative analysis [10]. Therefore,
the amount and, perhaps its contents, of EVs might be
one of the factors involved in infectivity/immunopathol-
ogy, since those structures contain several pro-inflamma-
tory molecules (see review in [18,29,36]). In order to
ascertain possible qualitative features of EVs, a prelimin-
ary analysis by immunoblotting was performed.
Consistent with previous observations, a distinct
protein profile was observed between the two strains
after probing with total anti-T. cruzi antibody. EVs
from` Y strain appear to be enriched in proteins ran-
ging from 80 kDa to 150 kDa. On the other hand, a
major 100-kDa protein was present in YuYu EVs.
However, after probing with anti-TS and anti-cruzi-
pain, a higher expression of those proteins was detected
for YuYu strain. Those data confirmed that this strain
Figure 5. Venn diagrams and cluster analysis of the peptides and proteins detected in EVs from Y and YuYu strains. (a) Analysis of
common individual peptides detected in the soluble (VF) and membrane bound fractions (EVs) of the material obtained after gel
filtration of the Y (top left) and YuYu strain (bottom left), or between the EVs (top right) and soluble fractions (VF) of the two strains.
(b) The same comparison was made using identified proteins.
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can release more vesicles, and those are enriched with
those molecules.
Proteomic analysis of VF and EVs also confirmed
that significant qualitative differences exist between
strains. Interestingly, some components are more
retained in the membrane-associated fractions of
YuYu EVs (which also contained several cytosolic pro-
teins), compared to Y. The proteomic analysis further
confirmed the enrichment for members of the TS gene
family. Several members of this gene family were
mainly found in the membrane bound fractions of
YuYu-EVs, while most of them were found in the
soluble fractions of Y-EVs. Those data are in agree-
ment with previous secretome analysis [37], showing
the presence of soluble and membrane bound TS from
T. cruzi trypomastigotes [13,38].
Most of the detected members of the TS superfamily
corresponded to the Group II and V (see Supplementary
Table I), which are encoded by the most abundant genes
in the genome. These proteins are found in the surface
of trypomastigotes [39,40] and contain a glycosylpho-
sphatidylinositol inositol (GPI) anchor [41]. Group V
displays only one typical sialidase domain and a
modified segment in lectin domain involved in the
interactions with host cell through the FLY sequence
[5,32]. This group predominated in the YuYu EV frac-
tion. In contrast, we detected the presence of the group
II more abundantly in the Y-EVs, which correspond to
the 85 kDa family of glycoproteins involved in the para-
site interaction with host cells. Those proteins harbour
the typical FLY sequence and two sialidase domains
[4,5,23,42] and monoclonal antibodies against one set
of these proteins, called Tc85, partially inhibits the host’s
cell invasion by the parasite [43].
Our analysis also detected more hits for Group I in
the YuYu EVs, which correspond to the proteins con-
taining TS activity, in agreement with our Western blot
analysis, which used an antibody to recognize the car-
boxy-terminal domain of the TS repeats, also denomi-
nated shed acute phase antigen (SAPA) [23]. The TS
enzymes are known to be released by trypomastigotes
and influence the host infectivity [12,44,45] and to
stimulate the production of IL-6 in intestinal micro-
vascular endothelial cells and peripheral blood mono-
nuclear cells [46]. It is important that some of these
proteins were also released in the soluble form as
Figure 6. Functional annotation of peptide sequences identified in EVs isolated from Y and YuYu strains of T. cruzi using Blast2go
software. (a) Biological processes, (b) Cellular components.
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Figure 7. Effect of EVs on macrophages. J774 macrophages (105) were pre-incubated for 1 h with EVs from Y and YuYu strains
containing each 1 or 10 µg of protein per mL, equivalent to 106 and 107 or just RPMI medium used as control. Cells were then
incubated for 2 h with trypomastigotes (10 parasites/cell), washed and the incubation proceeded for more 24 h. The cells were fixed
and stained with DAPI and the number of intracellular parasites determined in cells containing from 0 to 5 parasites/cells (a), 6 to 10
parasites/cells (b), 11 to 25 parasites/cells (c), and 26 to 50 parasites/cells (d). The values are means of duplicate experiments.
Figure 8. Effect of EVs on macrophages. LLC-MK2 (10
5) were pre-incubated 1 h with EVs from Y and YuYu strains containing each 1
or 10 µg of protein per mL, equivalent to 106 and 107, or just DMEM medium used as control. Cells were then incubated for 2 h with
trypomastigotes (10 parasites/cell), washed and the incubation proceeded for more 24 h. The cells were fixed and stained with DAPI
and the number of intracellular parasites determined in cells containing from 0 to 5 parasites/cells (a), 6 to 10 parasites/cells (b), and
11 to 25 parasites/cells (c). The values are means of duplicate experiments.
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shown before [47]. Interestingly, the SAPA repeats
were not largely detected in our analysis since they do
not contain lysine residues to generate short peptides
to be detected by our MS/MS analysis. We only
observed some hits for Group VIII, a less characterized
set of abundant genes and no members of Group III,
IV, VI, and VII. Group VI comprehends proteins with
160 kDa also involved in the interaction of trypomas-
tigotes with cells [48]. There it is possible that they
were expressed in relatively small amounts in trypo-
mastigotes or were not released with the EVs.
We have also identified several peptide sequences
corresponding to the mucin-associated surface proteins
(MASP), also detected in total proteome of T. cruzi
trypomastigotes [49]. Most of the MASP hits were
found in the EVs from both strains, although different
clusters were enriched in each one of them. MASP is a
member of a multigenic family, with variable amino acid
sequences containing a common N-terminal and a GPI-
anchoring sequence [50]. Therefore, these proteins
appear to be a principal component of the EVs mem-
branes, differently of the TS family that seems to be more
easily released in the soluble form. As the biological
function of MASP still remains to be determined, the
significance of our findings would require further inves-
tigation. In contrast, we did not detect abundant hits for
the mucin-like glycoproteins, known to be abundant in
the surface of trypomastigotes [1,27]. Previous studies
with highly purified tGPI-mucins suggested that these
molecules are difficult to analyse by conventional pro-
teomic analysis due to their amino acid composition,
sequence diversity, and extensive post-translational mod-
ifications [51]. Although the proteomic analysis from all
four T. cruzi stages was not able to identify those proteins
[49], a significant number of hits of TcMUCII mucins
were obtained through proteomic analysis of trypomas-
tigotes by 2D LC-MS/MS [49]. A recently discovered
family of proteins rich in serine, alanine, and proline
(SAP), with a sequence similar to MASP and shown to
be expressed and secreted to external medium by meta-
cyclic-trypomastigotes forms, and also to play a role in
host cell invasion and Ca2+ signalling [52,53], was min-
orly detected in our fractions.
Similar to Leishmania EVs [54], EVs from T. cruzi
strains also possess gp63, a surface glycoprotein with
protease activity. Previous studies already showed that
the gp63 from T. cruzi has a key role in parasite infection
[3] and complement inhibition [55]. We identified 7
clusters of this protein, and most of the hits were found
in the EVs from Y strain. Interestingly, for cruzipain,
which is a major cysteine proteinase released by trypo-
mastigotes [56], a few hits revealed this protein in our
proteomic analysis. It has been reported that cruzipain
activity remains in the supernatant of parasite culture
medium after high-speed centrifugation at 100,000 × g
[57]. Secretome analyses of other trypanosomatids
[13,14,38] such as Trypanosoma brucei, Leishmania dono-
vani, and Leishmania major have shown that a large
proportion, if not all of the secreted proteins are released
as membrane-bound vesicles [58–60], similar to mam-
malian exosomes. Interestingly, in L. donovani, the com-
position and number of secreted vesicles seems to be
regulated by conditions mimicking infection of host
cells [60]. Among the protozoan parasites, Plasmodium
[61] was shown to secrete EVs into the mouse plasma,
which contributes to inflammation by activating macro-
phages [62]. In our study, not only secreted but also
membrane bound proteins exhibited intraspecies poly-
morphisms that could be responsible for the differential
abilities of those strains to cause various outcomes in the
host during infection. In this sense, the ability of EVs
during invasion/proliferation mechanisms was assessed
during functional interaction with phagocytic and non-
phagocytic cells.
EVs of both strains showed marked differences
during the interaction of parasites with host cells.
They differentially modulated invasion by trypomas-
tigotes of the Y strain in two different cell lines.
J774A.1 macrophages pre-treated with EVs from Y
strain showed increased trypomastigote invasion,
whereas those from YuYu displayed increased intra-
cellular proliferation. The same situation was not
observed in LLC-MK2 cells suggesting that this
mechanism may be dependent on cellular type.
Consistent with those observations, different mechan-
isms of cell invasion by T. cruzi and the variable
responses of macrophages compared to non-phagocy-
tic cells were already reported [63]. Macrophages use
phagocytic process to internalize T. cruzi and [64]
this could be affected EVs. For example, we observed
that Toll-like receptors have been shown to modulate
invasion by the EVs, which contain GPI-anchors
(unpublished results). The growth of the intracellular
parasites could be also affected by the different escape
mechanisms from the parasitophorous vacuole
[65,66], or the specific induction of inflammasomes
in the macrophage lines [67]. One hypothesis to
explain those polymorphisms is the lower expression
of α-galactosyl residues in the YuYu EVs [10] since
pre-treatment with tGPI-mucins of Colombiana strain
(TcI) resulted in lower ability of infection compared
to Y strain (TcII) [26]. Those results could indicate
that terminal α-Gal residues are involved in the pro-
minent enhancement of host-cell infection by TCTs
mediated by EVs. It is also possible that these differ-
ential host cell–parasite interactions induced by
JOURNAL OF EXTRACELLULAR VESICLES 11
trypomastigote-derived vesicles could be determined
by distinct EV subpopulations (i.e. exosomes and
ectosomes), containing very diverse composition of
virulence factors and other host-cell modulators, as
previously described for metacyclic trypomastigotes
[13]. Future expression and functional proteomics of
different EV subpopulations could shed some light on
these disparate modulatory activities of trypomasti-
gotes vesicles on various host cells types.
In conclusion, this study assessed proteomic analysis
of EVs in different T. cruzi strains. Important qualitative
differences were found not only in the EVs, but also in
their secretome, may be determinant during the host
parasite interaction. More importantly, the presence of
virulence factors involved in pathogenesis and immuno-
pathology suggests their ability to modulate different
host inflammatory immune responses. Finally, those
EVs were able to differentially affect invasion/prolifera-
tion inside phagocytic and non-phagocytic cells.
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